Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-level Construal as a Novel Pathway for Affect Regulation and Cancer Control

NCT04620915 is registered in ClinicalTrials.gov with University of Oregon as lead sponsor.

NCT NCT04620915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04620915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-level Construal as a Novel Pathway for Affect Regulation and Cancer Control
Lead sponsor
University of Oregon
Phase
Not applicable
Overall status
Completed
Start date
October 11, 2021
Completion date
November 5, 2025
Enrollment
300 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, smoking cessation, smoking reduction